Dapagliflozin 10mg Tab: clinical trials recruiting now
10
Recruiting trials
15
Conditions studied
3
US states with sites
8
Countries
Phase breakdown
Phase 2 3
Phase 3 2
Phase 4 5
Conditions being studied
Recruiting trials involving Dapagliflozin 10mg Tab
- A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
- Cardiotoxicity in Breast Cancer Patients
- Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
- Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
- Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
- SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
- SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
- SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
- Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
Common questions
How many recruiting trials involve Dapagliflozin 10mg Tab?
10 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.